Recent Updates — BMRA

Biomerica announced that director David Moatazedi will not seek re-election to the board of directors at the company’s 2026 Annual Meeting of Stockholders scheduled for December 11, 2026. Mr. Moatazedi has served on the Board since December 2022 and currently chairs the Compensation Committee while serving on the Nominating and Corporate Governance and Audit Committees. The departure is not due to any dispute with the company. Biomerica operates in the diagnostics industry, developing molecular diagnostic tests.